{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:09:43Z","timestamp":1791155383824,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,11,17]],"date-time":"2011-11-17T00:00:00Z","timestamp":1321488000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1750-9378-6-22","type":"journal-article","created":{"date-parts":[[2011,12,15]],"date-time":"2011-12-15T19:24:21Z","timestamp":1323977061000},"source":"Crossref","is-referenced-by-count":22,"title":["Prevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South Africa"],"prefix":"10.1186","volume":"6","author":[{"given":"Mhairi","family":"Maskew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Patrick","family":"MacPhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Whitby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Egger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole L","family":"Wallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,17]]},"reference":[{"key":"302_CR1","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1001\/jama.279.6.450","volume":"279","author":"RS Hogg","year":"1998","unstructured":"Hogg RS, Heath KV, Yip B: Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA. 1998, 279: 450-4. 10.1001\/jama.279.6.450.","journal-title":"JAMA"},{"key":"302_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/00002030-200401020-00011","volume":"18","author":"S Jensen-Fangel","year":"2004","unstructured":"Jensen-Fangel S, Pedersen L, Pedersen C: Low mortality in HIV-infected patients starting highly active antiretroviral therapy: a comparison with the general population. AIDS. 2004, 18: 89-97. 10.1097\/00002030-200401020-00011.","journal-title":"AIDS"},{"key":"302_CR3","volume-title":"2008 report on the global AIDS epidemic","author":"UNAIDS","year":"2008","unstructured":"UNAIDS: 2008 report on the global AIDS epidemic. 2008, Accessed August 2010, [ http:\/\/www.unaids.org\/en\/dataanalysis\/epidemiology\/2008reportontheglobalaidsepidemic\/ ]"},{"key":"302_CR4","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S1470-2045(08)70175-X","volume":"9","author":"DM Parkin","year":"2008","unstructured":"Parkin DM, Sitas F, Chirenje M: Part I: Cancer in Indigenous Africans--burden, distribution, and trends. The lancet oncology. 2008, 9: 683-92. 10.1016\/S1470-2045(08)70175-X.","journal-title":"The lancet oncology"},{"key":"302_CR5","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1002\/ijc.23391","volume":"122","author":"L Stein","year":"2008","unstructured":"Stein L, Urban MI, O'Connell D: The spectrum of human immunodeficiency virus associated cancers in a South African black population: results from a case-control study, 1995-2004. International journal of cancer. 2008, 122: 2260-5. 10.1002\/ijc.23391.","journal-title":"International journal of cancer"},{"key":"302_CR6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0140-6736(95)91619-9","volume":"346","author":"D Whitby","year":"1995","unstructured":"Whitby D, Howard MR, Tenant-Flowers M: Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet. 1995, 346: 799-802. 10.1016\/S0140-6736(95)91619-9.","journal-title":"Lancet"},{"key":"302_CR7","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1038\/bjc.1998.717","volume":"78","author":"P Cook-Mozaffari","year":"1998","unstructured":"Cook-Mozaffari P, Newton R, Beral V, Burkitt DP: The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. British journal of cancer. 1998, 78: 1521-8. 10.1038\/bjc.1998.717.","journal-title":"British journal of cancer"},{"key":"302_CR8","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/S0959-8049(01)00120-4","volume":"37","author":"L Del Maso","year":"2001","unstructured":"Del Maso L, Serraino D, Franceschi S: Epidemiology of AIDS-related tumours in developed and developing countries. European Journal of Cancer. 2001, 37: 1188-1201. 10.1016\/S0959-8049(01)00120-4.","journal-title":"European Journal of Cancer"},{"issue":"Suppl 1","key":"302_CR9","first-page":"S34","volume":"21","author":"LP Jacobson","year":"1999","unstructured":"Jacobson LP, Yamashita TE, Detels R, Multicenter AIDS Cohort Study: Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Journal of acquired immune deficiency syndromes. 1999, 21 (Suppl 1): S34-41.","journal-title":"Journal of acquired immune deficiency syndromes"},{"key":"302_CR10","doi-asserted-by":"crossref","unstructured":"Ledergerber B, Telenti A, Egger M, Swiss HIV Cohort Study: Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. BMJ. 1999, 23-4. 319","DOI":"10.1136\/bmj.319.7201.23"},{"key":"302_CR11","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1002\/cncr.20309","volume":"100","author":"A Mocroft","year":"2004","unstructured":"Mocroft A, Kirk O, Clumeck N: The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study. Cancer. 2004, 100: 2644-54. 10.1002\/cncr.20309.","journal-title":"Cancer"},{"key":"302_CR12","first-page":"1","volume-title":"WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children","author":"World Health Organisation","year":"2006","unstructured":"World Health Organisation: WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. 2006, 1-48."},{"key":"302_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/00126334-200404010-00008","volume":"35","author":"K Anastos","year":"2004","unstructured":"Anastos K, Shi Q, French AL: Total lymphocyte count, hemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1-infected women receiving highly active antiretroviral therapy. Journal of acquired immune deficiency syndromes. 2004, 35: 383-92. 10.1097\/00126334-200404010-00008.","journal-title":"Journal of acquired immune deficiency syndromes"},{"key":"302_CR14","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1468-1293.2005.00290.x","volume":"6","author":"F Bonnet","year":"2005","unstructured":"Bonnet F, Thi\u00e9baut R, Ch\u00eane G: Determinants of clinical progression in antiretroviral naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002. HIV medicine. 2005, 6: 198-205. 10.1111\/j.1468-1293.2005.00290.x.","journal-title":"HIV medicine"},{"key":"302_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1758-2652-7-3-66","volume":"7","author":"D Jerene","year":"2005","unstructured":"Jerene D, Lindtjorn B: Disease Progression Among Untreated HIV-Infected Patients in South Ethiopia: Implications for Patient Care. Journal of the International AIDS Society. 2005, 7: 66-10.1186\/1758-2652-7-3-66.","journal-title":"Journal of the International AIDS Society"},{"key":"302_CR16","first-page":"620","volume":"39","author":"B Lau","year":"2005","unstructured":"Lau B, Gange SJ, Phair JP: Use of total lymphocyte count and hemoglobin concentration for monitoring progression of HIV infection. Journal of acquired immune deficiency syndromes. 2005, 39: 620-5.","journal-title":"Journal of acquired immune deficiency syndromes"},{"key":"302_CR17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/00042560-199811010-00007","volume":"19","author":"JJ Maas","year":"1998","unstructured":"Maas JJ, Dukers N, Krol A: Body mass index course in asymptomatic HIV-infected homosexual men and the predictive value of a decrease of body mass index for progression to AIDS. Journal of acquired immune deficiency syndromes and human retrovirology. 1998, 19: 254-9. 10.1097\/00042560-199811010-00007.","journal-title":"Journal of acquired immune deficiency syndromes and human retrovirology"},{"key":"302_CR18","first-page":"253","volume":"20","author":"J Mac\u00edas","year":"2001","unstructured":"Mac\u00edas J, Leal M, Delgado J: Usefulness of route of transmission, absolute CD8+ T-cell counts, and levels of serum tumor necrosis factor alpha as predictors of survival of HIV-1-infected patients with very low CD4 + T-cell counts. European journal of clinical microbiology & infectious diseases. 2001, 20: 253-9.","journal-title":"European journal of clinical microbiology & infectious diseases"},{"key":"302_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1423-0127-16-102","volume":"16","author":"C Obirikorang","year":"2009","unstructured":"Obirikorang C, Yeboah F: Blood haemoglobin measurement as a predictive indicator for the progression of HIV\/AIDS in resource-limited setting. Journal of biomedical science. 2009, 16: 102-10.1186\/1423-0127-16-102.","journal-title":"Journal of biomedical science"},{"key":"302_CR20","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/infdis\/172.3.648","volume":"172","author":"EA Operskalski","year":"1995","unstructured":"Operskalski EA, Stram DO, Lee H, Transfusion Safety Study Group: Human immunodeficiency virus type 1 infection: relationship of risk group and age to rate of progression to AIDS. The Journal of infectious diseases. 1995, 172: 648-55. 10.1093\/infdis\/172.3.648.","journal-title":"The Journal of infectious diseases"},{"key":"302_CR21","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/S0140-6736(00)02061-4","volume":"355","author":"Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action","year":"2000","unstructured":"Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action: Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Lancet. 2000, 355: 1131-7.","journal-title":"Lancet"},{"key":"302_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1742-6405-4-11","volume":"4","author":"SE Langford","year":"2007","unstructured":"Langford SE, Ananworanich J, Cooper D: Predictors of disease progression in HIV infection: a review. AIDS research and therapy. 2007, 4: 11-10.1186\/1742-6405-4-11.","journal-title":"AIDS research and therapy"},{"key":"302_CR23","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1097\/00002030-199813000-00011","volume":"12","author":"A Cozzi Lepri","year":"1998","unstructured":"Cozzi Lepri A, Katzenstein TL, Ullum H: The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection. AIDS. 1998, 12: 1639-43. 10.1097\/00002030-199813000-00011.","journal-title":"AIDS"},{"key":"302_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/00002030-200401020-00006","volume":"18","author":"A Phillips","year":"2004","unstructured":"Phillips A, Pezzotti P: Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era. AIDS. 2004, 18: 51-8.","journal-title":"AIDS"},{"key":"302_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/01.COH.0000194106.12816.b1","volume":"1","author":"AN Phillips","year":"2006","unstructured":"Phillips AN, Lundgren JD: The CD4 lymphocyte count and risk of clinical progression. Current opinion in HIV and AIDS. 2006, 1: 43-9. 10.1097\/01.COH.0000194106.12816.b1.","journal-title":"Current opinion in HIV and AIDS"},{"key":"302_CR26","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1097\/QAD.0b013e3282170a9d","volume":"21","author":"AN Phillips","year":"2007","unstructured":"Phillips AN, Gazzard B, Gilson R: Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count. AIDS. 2007, 21: 1717-21.","journal-title":"AIDS"},{"key":"302_CR27","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/00002030-200402200-00015","volume":"18","author":"D Bourboulia","year":"2004","unstructured":"Bourboulia D, Aldam D, Lagos D: Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia. AIDS. 2004, 18: 485-93. 10.1097\/00002030-200402200-00015.","journal-title":"AIDS"},{"key":"302_CR28","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1128\/JVI.76.6.2634-2640.2002","volume":"76","author":"J Wilkinson","year":"2002","unstructured":"Wilkinson J, Cope A, Gill J: Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active antiretroviral therapy. Journal of virology. 2002, 76: 2634-40. 10.1128\/JVI.76.6.2634-2640.2002.","journal-title":"Journal of virology"},{"key":"302_CR29","volume-title":"National Antiretroviral Treatment Guidelines","author":"National Department of Health","year":"2004","unstructured":"National Department of Health: National Antiretroviral Treatment Guidelines. 2004, First","edition":"First"},{"key":"302_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jim.2010.02.015","volume":"356","author":"GL Mbisa","year":"2010","unstructured":"Mbisa GL, Miley W, Gamache CJ: Detection of antibodies to Kaposi's sarcoma associated herpesvirus: a new approach using K8.1 ELISA and a newly developed recombinant LANA ELISA. Journal of immunological methods. 2010, 356: 39-46. 10.1016\/j.jim.2010.02.015.","journal-title":"Journal of immunological methods"},{"key":"302_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/ijc.10190","volume":"98","author":"de Sanjos\u00e9 S","year":"2002","unstructured":"Sanjos\u00e9 S de, Marshall V, Sol\u00e0 J: Prevalence of Kaposi's sarcoma-associated herpesvirus infection in sex workers and women from the general population in Spain. International journal of cancer. 2002, 98: 155-8. 10.1002\/ijc.10190.","journal-title":"International journal of cancer"},{"key":"302_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/jmv.20242","volume":"75","author":"W Klaskala","year":"2005","unstructured":"Klaskala W, Brayfield BP, Kankasa C: Epidemiological characteristics of human herpesvirus-8 infection in a large population of antenatal women in Zambia. Journal of medical virology. 2005, 75: 93-100. 10.1002\/jmv.20242.","journal-title":"Journal of medical virology"},{"key":"302_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1471-2334-8-111","volume":"8","author":"A Adjei","year":"2008","unstructured":"Adjei A, Armah HB, Gbagbo F: Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa. BMC infectious diseases. 2008, 8: 111-10.1186\/1471-2334-8-111.","journal-title":"BMC infectious diseases"},{"key":"302_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1750-9378-5-14","volume":"5","author":"BI Malope-Kgokong","year":"2010","unstructured":"Malope-Kgokong BI, Macphail P, Mbisa G: Kaposi's Sarcoma Associated-Herpes Virus (KSHV) Seroprevalence in Pregnant Women in South Africa. Infectious agents and cancer. 2010, 5: 14-10.1186\/1750-9378-5-14.","journal-title":"Infectious agents and cancer"},{"key":"302_CR35","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1056\/NEJM199906173402403","volume":"340","author":"F Sitas","year":"1999","unstructured":"Sitas F, Carrara H, Beral V: Antibodies against human herpesvirus 8 in black South African patients with cancer. The New England journal of medicine. 1999, 340: 1863-71. 10.1056\/NEJM199906173402403.","journal-title":"The New England journal of medicine"},{"key":"302_CR36","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1086\/314926","volume":"180","author":"Na Smith","year":"1999","unstructured":"Smith Na, Sabin Ca, Gopal R: Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. The Journal of infectious diseases. 1999, 180: 600-6. 10.1086\/314926.","journal-title":"The Journal of infectious diseases"},{"key":"302_CR37","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1056\/NEJM199804023381403","volume":"338","author":"JN Martin","year":"1998","unstructured":"Martin JN, Ganem DE, Osmond DH: Sexual transmission and the natural history of human herpesvirus 8 infection. The New England journal of medicine. 1998, 338: 948-54. 10.1056\/NEJM199804023381403.","journal-title":"The New England journal of medicine"},{"key":"302_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/jac\/45.suppl_4.15","volume":"45","author":"TF Schulz","year":"2000","unstructured":"Schulz TF: Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8): epidemiology and pathogenesis. Journal of Antimicrobial Chemotherapy. 2000, 45: 15-27.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"302_CR39","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1086\/424489","volume":"190","author":"SM Mbulaiteye","year":"2004","unstructured":"Mbulaiteye SM, Pfeiffer RM, Engels EA: Detection of Kaposi sarcoma-associated herpesvirus DNA in saliva and buffy-coat samples from children with sickle cell disease in Uganda. The Journal of infectious diseases. 2004, 190: 1382-6. 10.1086\/424489.","journal-title":"The Journal of infectious diseases"},{"key":"302_CR40","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/QAI.0b013e31802f12ea","volume":"44","author":"BI Malope","year":"2007","unstructured":"Malope BI, Pfeiffer RM, Mbisa G: Transmission of Kaposi sarcoma-associated herpesvirus between mothers and children in a South African population. Journal of acquired immune deficiency syndromes. 2007, 44: 351-5. 10.1097\/QAI.0b013e31802f12ea.","journal-title":"Journal of acquired immune deficiency syndromes"},{"key":"302_CR41","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1056\/NEJM200011093431904","volume":"343","author":"J Pauk","year":"2000","unstructured":"Pauk J, Huang ML, Brodie SJ: Mucosal shedding of human herpesvirus 8 in men. The New England journal of medicine. 2000, 343: 1369-77. 10.1056\/NEJM200011093431904.","journal-title":"The New England journal of medicine"},{"key":"302_CR42","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/QAD.0b013e3282f46582","volume":"22","author":"BI Malope","year":"2008","unstructured":"Malope BI, MacPhail P, Mbisa G: No evidence of sexual transmission of Kaposi's sarcoma herpes virus in a heterosexual South African population. AIDS. 2008, 22: 519-26. 10.1097\/QAD.0b013e3282f46582.","journal-title":"AIDS"},{"key":"302_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/aid.2007.0260","volume":"25","author":"R Minami","year":"2009","unstructured":"Minami R, Yamamoto M, Takahama S: Human herpesvirus 8 DNA load in the leukocytes correlates with the platelet counts in HIV type 1-infected individuals. AIDS research and human retroviruses. 2009, 25: 1-8. 10.1089\/aid.2007.0260.","journal-title":"AIDS research and human retroviruses"},{"key":"302_CR44","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/QAD.0b013e3282fc9c03","volume":"22","author":"EB El Amari","year":"2008","unstructured":"El Amari EB, Toutous-Trellu L, Gayet-Ageron A: Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era. AIDS. 2008, 22: 1019-28. 10.1097\/QAD.0b013e3282fc9c03.","journal-title":"AIDS"},{"key":"302_CR45","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1097\/00002030-200009290-00006","volume":"14","author":"TB Campbell","year":"2000","unstructured":"Campbell TB, Borok M, Gwanzura L: Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage. AIDS. 2000, 14: 2109-16. 10.1097\/00002030-200009290-00006.","journal-title":"AIDS"},{"key":"302_CR46","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1126\/science.279.5359.2103","volume":"279","author":"GS Ogg","year":"1998","unstructured":"Ogg GS, Jin X, Bonhoeffer S: Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science. 1998, 279: 2103-6. 10.1126\/science.279.5359.2103.","journal-title":"Science"},{"key":"302_CR47","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1067\/mai.2002.126226","volume":"110","author":"J Chinen","year":"2002","unstructured":"Chinen J, Shearer WT: Molecular virology and immunology of HIV infection. The Journal of allergy and clinical immunology. 2002, 110: 189-98. 10.1067\/mai.2002.126226.","journal-title":"The Journal of allergy and clinical immunology"},{"key":"302_CR48","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2893.2008.00970.x","volume":"15","author":"JT Blackard","year":"2008","unstructured":"Blackard JT, Sherman KE: HCV\/HIV co-infection: time to re-evaluate the role of HIV in the liver?. Journal of viral hepatitis. 2008, 15: 323-30. 10.1111\/j.1365-2893.2008.00970.x.","journal-title":"Journal of viral hepatitis"},{"key":"302_CR49","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/1743-422X-7-147","volume":"7","author":"N Chakraborty","year":"2010","unstructured":"Chakraborty N, Bhattacharyya S, De C: Incidence of multiple Herpesvirus infection in HIV seropositive patients, a big concern for Eastern Indian scenario. Virology journal. 2010, 7: 147-10.1186\/1743-422X-7-147.","journal-title":"Virology journal"},{"key":"302_CR50","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1159\/000069745","volume":"46","author":"B Shieh","year":"2003","unstructured":"Shieh B, Chang M-J, Ko W-C: Effects of multiple virus coinfections on disease progression in HIV-positive patients. Intervirology. 2003, 46: 105-13. 10.1159\/000069745.","journal-title":"Intervirology"},{"key":"302_CR51","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1177\/1545109706290171","volume":"5","author":"J Stebbing","year":"2006","unstructured":"Stebbing J, Powles T, Nelson M, Bower M: Significance of variation within HIV, EBV, and KSHV subtypes. Journal of the International Association of Physicians in AIDS Care. 2006, 5: 93-102. 10.1177\/1545109706290171.","journal-title":"Journal of the International Association of Physicians in AIDS Care"},{"key":"302_CR52","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1182\/blood-2005-04-1390","volume":"106","author":"E Caselli","year":"2005","unstructured":"Caselli E, Galvan M, Cassai E: Human herpesvirus 8 enhances human immunodeficiency virus replication in acutely infected cells and induces reactivation in latently infected cells. Blood. 2005, 106: 2790-7. 10.1182\/blood-2005-04-1390.","journal-title":"Blood"},{"key":"302_CR53","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1097\/00002030-200306130-00016","volume":"17","author":"Z Ait-Arkoub","year":"2003","unstructured":"Ait-Arkoub Z, Robert-Visse C, Calvez V: No influence of human herpesvirus 8 infection on the progression of HIV-1 infection in initially asymptomatic patients. AIDS. 2003, 17: 1394-6. 10.1097\/00002030-200306130-00016.","journal-title":"AIDS"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-9378-6-22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1750-9378-6-22\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-9378-6-22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T00:22:23Z","timestamp":1561076543000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/1750-9378-6-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,17]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["302"],"URL":"https:\/\/doi.org\/10.1186\/1750-9378-6-22","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,17]]},"article-number":"22"}}